Orlandi M, Spinella A, de Pinto M, Sandri G, De Santis G, Giuggioli D
J Scleroderma Relat Disord. 2024; :23971983241285212.
PMID: 39544903
PMC: 11559588.
DOI: 10.1177/23971983241285212.
Schmalzing M, Gernert M, Frohlich M, Henes J, Schwindl N, Zerhusen L
Front Immunol. 2024; 15:1436639.
PMID: 39512343
PMC: 11540678.
DOI: 10.3389/fimmu.2024.1436639.
Velauthapillai A, Vonk M, van den Ende C, Vriezekolk J
J Scleroderma Relat Disord. 2024; 9(3):223-232.
PMID: 39381052
PMC: 11457772.
DOI: 10.1177/23971983241242836.
Farhat M, Guerreschi P, Morell-Dubois S, Deken V, Labreuche J, Sanges S
J Scleroderma Relat Disord. 2024; 9(2):124-133.
PMID: 38910601
PMC: 11188849.
DOI: 10.1177/23971983241231620.
Sari F, Bazancir Apaydin Z, Apaydin H, Kayaalp M, Erden A, Guven S
Arch Rheumatol. 2024; 39(1):52-59.
PMID: 38774706
PMC: 11104756.
DOI: 10.46497/ArchRheumatol.2023.10183.
Objective Non-Invasive Bio-Parametric Evaluation of Regenerated Skin: A Comparison of Two Acellular Dermal Substitutes.
Rampazzo S, Ferrari M, Sotgiu M, Piu G, Solinas M, Usai N
Life (Basel). 2024; 14(1).
PMID: 38255736
PMC: 10817643.
DOI: 10.3390/life14010121.
Performance of myotonometer in the assessment of skin involvement in systemic sclerosis.
Ozturk O, Sahin D, Acar A, Saldiran T, Uzun N, Sen N
Clin Rheumatol. 2023; 43(2):695-705.
PMID: 38114818
DOI: 10.1007/s10067-023-06848-6.
Effects of a Resilience-Building Energy Management Program on Fatigue and Other Symptoms in Systemic Sclerosis: A Randomized Controlled Trial.
Murphy S, Chen Y, Alore M, Hicks S, Pape A, Hassett A
Arthritis Care Res (Hoboken). 2023; 76(3):318-327.
PMID: 37846437
PMC: 10922781.
DOI: 10.1002/acr.25253.
Systemic Sclerosis Patients Experiencing Mindfulness-Based Stress Reduction Program: The Beneficial Effect on Their Psychological Status and Quality of Life.
El Aoufy K, Pezzutto A, Pollina A, Rasero L, Bambi S, Bellando-Randone S
Int J Environ Res Public Health. 2023; 20(3).
PMID: 36767877
PMC: 9915443.
DOI: 10.3390/ijerph20032512.
Clinical significance and usefulness of rehabilitation for systemic sclerosis.
Mugii N, Hamaguchi Y, Maddali-Bongi S
J Scleroderma Relat Disord. 2022; 3(1):71-80.
PMID: 35382125
PMC: 8892873.
DOI: 10.1177/2397198317750043.
Multi-Method Approach in the Assessment of Alexithymia in Patients With Scleroderma: Use of Two Different Tools.
Dattolo A, Samela T, Abeni D, Pallotta S, Sampogna F
Front Psychol. 2021; 12:696345.
PMID: 34912260
PMC: 8666454.
DOI: 10.3389/fpsyg.2021.696345.
Fatigue Predicts Future Reduced Social Participation, not Reduced Physical Function or Quality of Life in People with Systemic Sclerosis.
Murphy S, Whibley D, Kratz A, Poole J, Khanna D
J Scleroderma Relat Disord. 2021; 6(2):187-193.
PMID: 34337153
PMC: 8320783.
DOI: 10.1177/2397198320965383.
Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS).
Pettersson H, Alexanderson H, Poole J, Varga J, Regardt M, Russell A
Best Pract Res Clin Rheumatol. 2021; 35(3):101695.
PMID: 34217607
PMC: 8478716.
DOI: 10.1016/j.berh.2021.101695.
Rehabilitation Interventions in Systemic Sclerosis: A Systematic Review and Future Directions.
Murphy S, Poole J, Chen Y, Lescoat A, Khanna D
Arthritis Care Res (Hoboken). 2021; 74(1):59-69.
PMID: 34165263
PMC: 8695630.
DOI: 10.1002/acr.24737.
Psychological and self-management support for people with vasculitis or connective tissue diseases: UK health professionals' perspectives.
Robson J, Shepherd M, Harper L, Ndosi M, Austin K, Flurey C
Rheumatol Adv Pract. 2020; 4(2):rkaa016.
PMID: 32968704
PMC: 7494082.
DOI: 10.1093/rap/rkaa016.
Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysis.
Denton C, Laird B, Moros L, Luna Flores J
Clin Rheumatol. 2020; 40(4):1399-1407.
PMID: 32915347
PMC: 7943486.
DOI: 10.1007/s10067-020-05371-2.
Fatigue and Its Association With Social Participation, Functioning, and Quality of Life in Systemic Sclerosis.
Murphy S, Kratz A, Whibley D, Poole J, Khanna D
Arthritis Care Res (Hoboken). 2019; 73(3):415-422.
PMID: 31841268
PMC: 7295677.
DOI: 10.1002/acr.24122.
Factors associated with quality of life in systemic sclerosis: a cross-sectional study.
Sierakowska M, Doroszkiewicz H, Sierakowska J, Olesinska M, Grabowska-Jodkowska A, Brzosko M
Qual Life Res. 2019; 28(12):3347-3354.
PMID: 31482431
PMC: 6863937.
DOI: 10.1007/s11136-019-02284-9.
What moves the rheumatologist? Unravelling decision making in the referral of systemic sclerosis patients to health professionals: a qualitative study.
Stocker J, Cup E, Vonk M, van den Hoogen F, Nijhuis-van Der Sanden M, Staal J
Rheumatol Adv Pract. 2019; 2(2):rky027.
PMID: 31431973
PMC: 6649894.
DOI: 10.1093/rap/rky027.
Neuropathic pain: is it an underestimated symptom in systemic sclerosis?.
Cuzdan N, Turk I, Sarpel T, Erken E, Alparslan Z
Clin Rheumatol. 2018; 37(7):1845-1851.
PMID: 29691771
DOI: 10.1007/s10067-018-4107-1.